Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Bosaeed

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Vaccines|August 26, 2022
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and CamelsNaif Khalaf Alharbi, Fahad Aljamaan, Haya A Aljami, et al.
Journal of Infection and Public Health|April 26, 2022
Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi ArabiaNaif Khalaf Alharbi, Jaffar A Al-Tawfiq, Suliman Alghnam, et al.
Trials|November 1, 2020
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trialMohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, et al.
Journal of Multidisciplinary Healthcare|August 6, 2021
Early Prediction of COVID-19 Ventilation Requirement and Mortality from Routinely Collected Baseline Chest Radiographs, Laboratory, and Clinical Data with Machine LearningAbdulrhman Fahad Aljouie, Ahmed Almazroa, Yahya Bokhari, et al.
BMJ Open|April 15, 2021
Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, et al.
Journal of Infection and Public Health|October 25, 2023
Assessing the influence of COVID-19 on influenza prevalence: A multicenter time series studyKhalid Bin Saleh, Hisham A Badreldin, Tariq Alqahtani, et al.
Genomics|April 10, 2021
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortalityJahad Alghamdi, Manal Alaamery, Tlili Barhoumi, et al.
The Lancet. Microbe|November 9, 2021
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trialMohammad Bosaeed, Hanan H Balkhy, Sultan Almaziad, et al.
BMC Infectious Diseases|February 7, 2023
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort studyKhalid Al Sulaiman, Ohoud Aljuhani, Hisham A Badreldin, et al.
Infectious Diseases and Therapy|July 28, 2021
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled TrialMohammad Bosaeed, Ebrahim Mahmoud, Ahmad Alharbi, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Vaccines|August 26, 2022
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and CamelsNaif Khalaf Alharbi, Fahad Aljamaan, Haya A Aljami, et al.
Journal of Infection and Public Health|April 26, 2022
Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi ArabiaNaif Khalaf Alharbi, Jaffar A Al-Tawfiq, Suliman Alghnam, et al.
Trials|November 1, 2020
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trialMohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, et al.
Journal of Multidisciplinary Healthcare|August 6, 2021
Early Prediction of COVID-19 Ventilation Requirement and Mortality from Routinely Collected Baseline Chest Radiographs, Laboratory, and Clinical Data with Machine LearningAbdulrhman Fahad Aljouie, Ahmed Almazroa, Yahya Bokhari, et al.
BMJ Open|April 15, 2021
Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, et al.
Journal of Infection and Public Health|October 25, 2023
Assessing the influence of COVID-19 on influenza prevalence: A multicenter time series studyKhalid Bin Saleh, Hisham A Badreldin, Tariq Alqahtani, et al.
Genomics|April 10, 2021
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortalityJahad Alghamdi, Manal Alaamery, Tlili Barhoumi, et al.
The Lancet. Microbe|November 9, 2021
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trialMohammad Bosaeed, Hanan H Balkhy, Sultan Almaziad, et al.
BMC Infectious Diseases|February 7, 2023
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort studyKhalid Al Sulaiman, Ohoud Aljuhani, Hisham A Badreldin, et al.
Infectious Diseases and Therapy|July 28, 2021
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled TrialMohammad Bosaeed, Ebrahim Mahmoud, Ahmad Alharbi, et al.
Pageof 7